Tibra Equities Europe’s iShares Biotechnology ETF IBB Stock Holding History

Tibra Equities Europe’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,335	Closed	-$2.17M	–	61
2020 Q4	$2.17M	Sell	14,335 -16,054	-53%	-$2.29M	0.22%	53
2020 Q3	$4.12M	Buy	+30,389	New	+$4.12M	0.87%	28
2020 Q1	–	Sell	-291,002	Closed	-$35.1M	–	64
2019 Q4	$35.1M	Buy	291,002 +199,746	+219%	+$22.3M	4.88%	5
2019 Q3	$9.08M	Sell	91,256 -448,740	-83%	-$47M	1.12%	24
2019 Q2	$58.9M	Buy	+539,996	New	+$57.4M	4.36%	3
2019 Q1	–	Sell	-166,769	Closed	-$16.1M	–	419
2018 Q4	$16.1M	Buy	166,769 +117,781	+240%	+$12.5M	2.65%	9
2018 Q3	$5.97M	Buy	+48,988	New	+$5.77M	0.71%	32
2018 Q1	–	Sell	-214,152	Closed	-$22.9M	–	226
2017 Q4	$22.9M	Buy	+214,152	New	+$22.9M	9.81%	1

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tibra Equities Europe's IBB Position: Q1 2021 in Review

Tibra Equities Europe sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 14,335 shares — an estimated $2.17M sold.

Tibra Equities Europe first reported a position in IBB in Q4 2017 and held it in 8 quarters. The position peaked at $58.9M in Q2 2019. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Tibra Equities Europe reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Tibra Equities Europe sold 14,335 iShares Biotechnology ETF shares in Q1 2021, an estimated $2.17M.
Tibra Equities Europe first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 8 quarters.
Tibra Equities Europe's iShares Biotechnology ETF position peaked at $58.9M in Q2 2019.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Tibra Equities Europe's 13F filing for Q1 2021, filed 17 May 2021.